Recruiting
Phase 1

Beta-blocker vs. Rate Control

Sponsor:

University of Vermont

Code:

NCT05745337

Conditions

Atrial Fibrillation

Diastolic Dysfunction

HFpEF - Heart Failure With Preserved Ejection Fraction

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by University of Vermont on 2023-03-03.